C79.81
Secondary malignant neoplasm of breast
Clinical Classification Guidelines
Medical Intelligence & Overview
Secondary malignant neoplasm of the breast, classified under ICD-10 code C79.81, refers to a cancer that has spread to the breast from another part of the body. Unlike primary breast cancer, which originates in the breast tissue itself, secondary neoplasms are considered metastatic tumors, indicating that cancer cells have traveled through the bloodstream or lymphatic system to reach the breast. This diagnosis often signifies advanced disease stages with complex treatment considerations. Recognizing this condition is crucial for devising appropriate management strategies and understanding prognosis.
Causes & Symptoms
Clinical Causes: Spreading of primary cancer from other organs such as lung, ovary, stomach, or gastrointestinal tract Metastatic dissemination through blood or lymphatic pathways Progression of existing cancer that has metastasized to the breast tissue
Key Symptoms: New or unusual lumps or masses in the breast Changes in breast size, shape, or appearance Skin alterations such as redness, dimpling, or puckering of the breast tissue Nipple changes, including retraction or discharge Localized pain or discomfort, although some cases may be painless Swelling or enlarged lymph nodes in the armpit or collarbone region
Diagnostic & Treatment
Diagnosis Path: Diagnosing secondary malignant neoplasm of the breast involves a combination of imaging studies and tissue analysis. Techniques include mammography, ultrasound, or MRI to identify abnormal masses. Confirmation requires a biopsy, where tissue samples are examined microscopically to detect metastatic cancer cells. Additional tests such as PET scans or CT scans help determine the origin and extent of the primary tumor, as well as the spread within the body. A comprehensive diagnostic process is essential to distinguish secondary neoplasms from primary breast cancers and to guide treatment planning.
Treatment Protocols: Management of secondary malignant neoplasm of the breast typically involves a multidisciplinary approach. Treatment options may include systemic therapies such as chemotherapy, targeted therapy, immunotherapy, or hormonal therapy, depending on the primary cancer type and receptor status. Surgical intervention is less common but may be considered for symptom relief or specific cases. Radiation therapy could be used to control local symptoms. Palliative care plays an important role in improving quality of life, managing pain, and addressing other symptom burdens. Tailored treatment plans rely on factors such as overall health, extent of disease spread, and patient preferences.
Clinical Advice & FAQs
Billing Guidance
Is C79.81 a billable ICD-10 code?
Yes, C79.81 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C79.81?
Clinical documentation must specify the nature of Secondary malignant neoplasm of breast and any associated comorbidities for accurate reporting.
Cite this Clinical Reference